Sign in

NCT04735458Recruiting

Investigating Inhibitory Control Networks in Parkinson's Disease

Source: ClinicalTrials.gov · Last updated 2 Dec 2025

Brief summary (registry, in English)

The purpose of this study is to investigate the brain activity associated with non-motor symptoms of movement disorders, including Parkinson's disease and essential tremor. These movement disorders commonly have significant non-motor features also, including depression, cognitive impairment, decreased attention, and slower processing speeds. The investigators are interested in the brain activity associated with these symptoms, and perform recordings of the surface of the brain, in addition to the typical recordings the investigators perform, during routine deep brain stimulation (DBS) surgery.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
140 (estimated)
First submitted
28 Jan 2021
Start date
1 Apr 2021
Primary completion date
31 Mar 2027
Lead sponsor
University of Alabama at Birmingham
NCT number
NCT04735458

What you commit to

  • Study type: Interventional
  • Planned participants: 140
  • From 1 Apr 2021 to the primary completion date, 31 Mar 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • History of prior ischemic/hemorrhagic stroke, subdural hemorrhage, or seizure

Age

  • Age younger than 18

Other

  • Inability to provide full and informed consent
  • Are not able to participate in study-related activities

Who the study is looking for

  • Eligible for surgery based on multi-disciplinary consensus review
  • Have a diagnosis of Parkinson's disease or Essential Tremor
  • Have a diagnosis of medically-refractory movement disorder (Parkinson's disease, Essential Tremor, or dystonia)
  • Willingness to participate in the paradigms described in the protocol

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of Alabama at Birmingham
Coordinator of this site? Confirm its status
BirminghamUnited StatesRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.